For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Op-Eds
Cholesterol Drug Scare Shenanigans
Why is the editor of the New England Journal of Medicine encouraging a cancer scare over the cholesterol-lowering drug Vytorin? Is he overcompensating for past…
News Release
Public Funding for Stem Cell Research: Boon or Boondoggle?
Debates over the ethics of research using human embryonic stem cells continue long after the Bush Administration’s ban on federal tax-funding for such research. But,…
Study
Public Stem Cell Research Funding
The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…
Newsletter
West Nile, Union Corruption and Federal Courts
The West Nile Virus has infected individuals in 28 states so far this year. The Los Angeles Times publishes a 3-part series on corruption allegations…
Blog
Anna Tomalis, R.I.P.
Last Friday, I attended the funeral of a remarkable 13-year-old girl named Anna Tomalis. For the past three years, Anna had been battling terminal…